CRI and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family.
Discussion of the next wave of scientific advancements in immuno-oncology by panel of industry and academic leaders
Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment.
30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment
Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This April for Esophageal Cancer Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to esophageal cancer.
Spring equinox marks a moment of renewal. Why not choose a personal goal to invest in yourself and the world around you? Join ’21 Challenge for Cancer Research.